Screener
Sionna Therapeutics SION Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 45,075,651 and 44,723,585 shares issued, 45,075,651 and 44,723,585 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 45 | 45 |
| Additional paid-in capital | 571,380 | 562,602 |
| Accumulated other comprehensive (loss) income | (84) | 540 |
| Accumulated deficit | (283,133) | (256,354) |
| Total stockholders’ equity | 288,208 | 306,833 |
| Total liabilities and stockholders’ equity | $305,039 | $325,953 |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's retained earnings?
- Sionna Therapeutics (SION) reported retained earnings of -$283.13M in Q1 2026.
- How has Sionna Therapeutics's retained earnings changed year-over-year?
- Sionna Therapeutics's retained earnings decreased by 43.3% year-over-year, from -$197.57M to -$283.13M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Sionna Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude